Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy
NCT01192087
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Adenoid Cystic Carcinoma
Interventions
DRUG:
Cetuximab
Sponsor
Heidelberg University
Collaborators
[object Object]
[object Object]
[object Object]